Get the Stockscreener App
4.83
0.82%
-0.04
After Hours:
4.70
-0.13
-2.69%
Tenax Therapeutics Inc stock is traded at $4.83, with a volume of 24,121.
It is down -0.82% in the last 24 hours and up +22.28% over the past month.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
See More
Previous Close:
$4.87
Open:
$4.86
24h Volume:
24,121
Relative Volume:
0.44
Market Cap:
$16.60M
Revenue:
-
Net Income/Loss:
$-10.10M
P/E Ratio:
-1.4592
EPS:
-3.31
Net Cash Flow:
$-9.34M
1W Performance:
-3.35%
1M Performance:
+22.28%
6M Performance:
+36.09%
1Y Performance:
-84.17%
1-Day Range:
$4.81
$5.00
1-Week Range:
$4.50
$5.00
52-Week Range:
$2.77
$33.44
Tenax Therapeutics Inc Stock (TENX) Company Profile
Name
Tenax Therapeutics Inc
Sector
Industry
Phone
919-855-2100
Address
101 GLEN LENNOX DRIVE, CHAPEL HILL, NC
Compare TENX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| TENX | 4.83 | 16.60M | 0 | -10.10M | -9.34M | -3.31 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Tenax Therapeutics Inc Stock (TENX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-18-17 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Dec-16-14 | Initiated | MLV & Co | Buy |
| Nov-18-14 | Initiated | WallachBeth | Buy |
Tenax Therapeutics Inc Stock (TENX) Latest News
Tenax Therapeutics: Q3 Earnings Snapshot - New Haven Register
Tenax Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update - GlobeNewswire
Tenax Therapeutics Secures $100M Funding, Extends Runway to 2027 Despite Wider Q3 Loss | TENX Stock News - StockTitan
Tenax Therapeutics (NASDAQ:TENX) Stock Price Passes Above 200-Day Moving Average – Here’s Why - Defense World
Tenax Therapeutics to Present at the Guggenheim Healthcare Innovation Conference - The Manila Times
Tenax Therapeutics expands stock incentive plan By Investing.com - Investing.com Australia
Tenax Therapeutics expands stock incentive plan - Investing.com
Tenax Therapeutics Expands Stock Incentive Plan - TipRanks
Analysts Set Tenax Therapeutics, Inc. (NASDAQ:TENX) Target Price at $170.67 - Defense World
FY2024 Earnings Estimate for TENX Issued By Leerink Partnrs - Defense World
Tenax Therapeutics (NASDAQ:TENX) Coverage Initiated at Leerink Partners - Defense World
Leerink Partnrs Upgrades Tenax Therapeutics (NASDAQ:TENX) to “Strong-Buy” - Defense World
This Sempra Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Warning: TENX is at high risk of performing badly - MSN
Guggenheim Initiates Coverage of Tenax Therapeutics (TENX) with Buy Recommendation - Nasdaq
Tenax Therapeutics, Inc. to Post Q3 2024 Earnings of ($1.50) Per Share, William Blair Forecasts (NASDAQ:TENX) - Defense World
William Blair Initiates Coverage of Tenax Therapeutics (TENX) with Outperform Recommendation - MSN
SEC Form DEF 14A filed by Tenax Therapeutics Inc. - Quantisnow
StockNews.com Initiates Coverage on Tenax Therapeutics (NASDAQ:TENX) - Defense World
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Tencent Music Entertainment Group (NYSE:TME) Shares Gap Up to $10.18 - MarketBeat
Tencent Music Entertainment Group Target of Unusually High Options Trading (NYSE:TME) - MarketBeat
Farallon Capital Management LLC Buys Shares of 2,000 TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World
Tencent Music Entertainment Group (TME): Among the Worst Affordable Stocks to Buy Under $10 - Insider Monkey
Transmedics Group Inc [TMDX] Stock sold by Insider Hassanein Waleed H for $1.32 million - Knox Daily
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch
Hood River Capital Management LLC Acquires New Position in TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World
TME’s Market Whiplash: 14.48% YTD Rise, 0.63% Rise in 30 Days - The InvestChronicle
Tenon Medical to implement reverse stock split - MSN
TNON’s Market Whiplash: -56.72% YTD Decline, 36.75% Rise in 30 Days - The InvestChronicle
Tenet Healthcare Co. (NYSE:THC) is Khrom Capital Management LLC’s 7th Largest Position - Defense World
TransMedics Group, Inc. (NASDAQ:TMDX) Shares Sold by Apis Capital Advisors LLC - Defense World
Market Recap Check: Tenon Medical Inc (TNON)’s Positive Finish at 5.47, Up/Down 8.75 - The Dwinnex
A stock that deserves closer examination: Tenon Medical Inc (TNON) - US Post News
Sei Investments Co. Grows Stock Position in Tencent Music Entertainment Group (NYSE:TME) - Defense World
TransMedics Group, Inc. (NASDAQ:TMDX) Position Cut by Ensign Peak Advisors Inc - Defense World
Bank of New York Mellon Corp Purchases Shares of 116,658 TScan Therapeutics, Inc. (NASDAQ:TCRX) - MarketBeat
AE Wealth Management LLC Makes New Investment in Tenet Healthcare Co. (NYSE:THC) - Defense World
Meiji Yasuda Asset Management Co Ltd. Sells 140 Shares of Tenet Healthcare Co. (NYSE:THC) - Defense World
State of New Jersey Common Pension Fund D Has $1.97 Million Stock Position in TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World
Dimensional Fund Advisors LP Sells 142,950 Shares of Tenet Healthcare Co. (NYSE:THC) - Defense World
Renaissance Technologies LLC Acquires 68,100 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World
DekaBank Deutsche Girozentrale Grows Stock Position in Tenet Healthcare Co. (NYSE:THC) - Defense World
Renaissance Technologies LLC Takes Position in Tenet Healthcare Co. (NYSE:THC) - Defense World
Why Tenon Medical (TNON) Stock Is Skyrocketing Friday - Benzinga
Federated Hermes Inc. Invests $3.35 Million in TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World
Tenet Healthcare (NYSE:THC) Sets New 52-Week High at $167.29 - MarketBeat
Tenon Medical Announces Issuance of Three Notices of Allowance for Patent Applications from the USPTO - StockTitan
Blair William & Co. IL Decreases Stock Position in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
Mutual of America Capital Management LLC Sells 5,894 Shares of Tenet Healthcare Co. (NYSE:THC) - MarketBeat
Waleed H. Hassanein Sells 8,625 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) Stock - Defense World
Tenax Therapeutics Inc Stock (TENX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.66%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):